BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/25/2023 4:10:54 PM | Browse: 86 | Download: 192
 |
Received |
|
2022-11-10 13:52 |
|
Peer-Review Started |
|
2022-11-10 13:55 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-12-26 02:10 |
|
Revised |
|
2023-01-29 13:13 |
|
Second Decision |
|
2023-04-17 03:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-04-17 07:22 |
|
Articles in Press |
|
2023-04-17 07:22 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-05-06 08:06 |
|
Publish the Manuscript Online |
|
2023-05-25 16:10 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Genetics & Heredity |
| Manuscript Type |
Case Report |
| Article Title |
Enzyme replacement therapy in two patients with classic Fabry disease from the same family tree: Two case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yuki Harigane, Issei Morimoto, O Suzuki, Jumpei Temmoku, Takayuki Sakamoto, Kohichiro Nakamura, Kazuo Machii and Masayuki Miyata |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Red Cross Hospital Research and Training Fund |
Fukushima R.C. Hosp. No. 57 |
|
| Corresponding Author |
Masayuki Miyata, FACP, MD, PhD, Doctor, Center of Internal Medicine for Rheumatology and Collagen Disease, Fukushima Red Cross Hospital, 7-7 Yashima-cho, Fukushima City 960-8530, Fukushima, Japan. metm@nifty.com |
| Key Words |
Enzyme replacement therapy; Fabry disease; Pedigree; Left ventricular hypertrophy; α-galactosidase; Case report |
| Core Tip |
Fabry disease (FD) is an inherited metabolic disorder, caused by a genetic mutation or decreased α-galactosidase activity in lysosomes. Enzyme replacement therapy (ERT) is a promising treatment for FD. Few reports have compared the effect of ERT in older adult populations vs. that in populations in their 30s. Here we report the effect of ERT in an older adult and a patient in his mid-30s from the same FD family. We demonstrated that ERT is sufficiently effective for patients in their mid-30s if the major organs such as the brain, heart and kidney are not severely damaged. |
| Publish Date |
2023-05-25 16:10 |
| Citation |
Harigane Y, Morimoto I, Suzuki O, Temmoku J, Sakamoto T, Nakamura K, Machii K, Miyata M. Enzyme replacement therapy in two patients with classic Fabry disease from the same family tree: Two case reports. World J Clin Cases 2023; 11(15): 3542-3551 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i15/3542.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i15.3542 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
